FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ P...
FDA Recall #D-0025-2026 — Class III — October 9, 2025
Product Description
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Recalling Firm
STAQ Pharma, Inc. — Denver, CO
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Distribution
Nationwide in the U.S.
Code Information
Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated